CROPS NEWS
Wed Jan 30, 2013 10:46 AM CST

(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.

Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement

The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.

The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.

Agradis has ...

Quick View
Related News Stories
Under the Agridome
Crop Tech Corner
USDA Develops GMO-Free Label
Food Industry Seeks GMO Label Law Block
Production Blog
EU OKs High-Oleic Traits
EU Advances Biotech Opt-Out
Crop Tech Corner
EU Could Alter Biotech Trade
Bean Oil Health Questioned